{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:36:11Z","timestamp":1787027771014,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad UTE, Quito, Ecuador"},{"id":[{"id":"https:\/\/ror.org\/00dmdt028","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Breast cancer (BC) is the most frequently diagnosed malignancy among women worldwide, yet tumor genomic data from Latin American and admixed populations remain limited. This gap affects the interpretation of cancer-associated variants and may limit the representation of these populations in genomic research. This study aimed to characterize the genomic landscape of breast tumors from Ecuadorian women and contextualize variant interpretation through genetic ancestry analysis. Methods: Breast tissue samples from 23 Ecuadorian mestizo women with suspected malignancy were analyzed. After histopathological confirmation, 21 breast tumors were included in the final cohort. Targeted next-generation sequencing was performed using a 94-gene cancer panel. Variants were annotated and classified according to clinical significance. Because matched normal DNA was unavailable, variant allele frequency was used as an exploratory approach to infer putative somatic, putative germline, indeterminate, or putative homozygous germline profiles. Putative germline and indeterminate variants were interpreted using ACMG\/AMP criteria, whereas putative somatic variants were evaluated using the AMP\/ASCO\/CAP framework. Genetic ancestry was inferred using ancestry-informative insertion\/deletion markers. Results: Seventy-two unique variants across 40 genes were identified, including 14 pathogenic, 10 likely pathogenic, and 48 variants of uncertain significance. Pathogenic and likely pathogenic alterations were detected in clinically relevant genes, including TP53, BRCA2, PTEN, CDH1, RAD51C, MSH6, NF1, CYLD, and SDHB. Variants of uncertain significance represented 66.7% of all detected variants and affected several cancer-associated and DNA repair genes. The cohort showed a trihybrid ancestry profile, with predominant Native American ancestry, followed by European and African contributions. Conclusions: This study expands BC genomic data from an underrepresented Ecuadorian cohort and highlights the coexistence of clinically relevant alterations with a high burden of variants of uncertain significance. The findings underscore the limitations of tumor-only sequencing and current variant interpretation frameworks in admixed populations. Larger studies integrating matched normal DNA, ancestry-informed analyses, functional validation, and broader sequencing strategies could help improve variant interpretation in Latin American populations.<\/jats:p>","DOI":"10.3390\/cancers18121964","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:56:31Z","timestamp":1781675791000},"page":"1964","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genomic Profiling of Breast Cancer in an Ecuadorian Cohort Reveals Clinically Relevant Variants and Ancestry-Related Interpretation Challenges"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4102-3965","authenticated-orcid":false,"given":"Ana Karina","family":"Zambrano","sequence":"first","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica, Quito 170129, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-3281","authenticated-orcid":false,"given":"Rafael","family":"Tamayo-Trujillo","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica, Quito 170129, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Guevara-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica, Quito 170129, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elius","family":"Paz-Cruz","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica, Quito 170129, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-2614","authenticated-orcid":false,"given":"Viviana A.","family":"Ruiz-Pozo","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica, Quito 170129, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-6046","authenticated-orcid":false,"given":"Santiago","family":"Cadena-Ullauri","sequence":"additional","affiliation":[{"name":"Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigaci\u00f3n Gen\u00e9tica y Gen\u00f3mica, Quito 170129, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9702-6618","authenticated-orcid":false,"given":"Alejandro","family":"Cabrera-Andrade","sequence":"additional","affiliation":[{"name":"Carrera de Enfermer\u00eda, Facultad de Ciencias de la Salud, Universidad de las Am\u00e9ricas, Quito 170125, Ecuador"},{"name":"Grupo de Bio-Quimioinform\u00e1tica, Universidad de las Am\u00e9ricas, Quito 170125, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Israel","family":"Llerena B\u00e9jar","sequence":"additional","affiliation":[{"name":"Private Practice in Gynecology and Breast Health, Quito 170519, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: Pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"20816","DOI":"10.1038\/s41598-025-05276-7","article-title":"A comprehensive epidemiological analysis of breast cancer in the Eastern Province of Saudi Arabia","volume":"15","author":"Almohanna","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_3","unstructured":"World Health Organization (2025, November 27). Cancer Today [Internet]. International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/today\/en\/dataviz\/pie?mode=cancer&group_populations=1&cancers=20&populations=218&types=1&sexes=2&multiple_populations=0."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.56294\/saludcyt2024741","article-title":"Characterization of breast cancer detection programs in the Americas region with a focus on Ecuador","volume":"4","author":"Loor","year":"2024","journal-title":"Salud Cienc. Tecnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/CM9.0000000000001814","article-title":"Global and regional trends in incidence and mortality of female breast cancer and associated factors at national level in 2000 to 2019","volume":"135","author":"Luo","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/wjs.70096","article-title":"Breast Cancer Heterogeneity in Latin America: A Scoping Review of Clinical-Pathological Characteristics, Molecular Subtypes, and Survival","volume":"49","author":"Merck","year":"2025","journal-title":"World J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"26717","DOI":"10.1038\/s41598-025-12883-x","article-title":"Patterns and prognostic implications of distant metastasis in breast cancer based on SEER population data","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41523-021-00363-0","article-title":"Subclonal heterogeneity and evolution in breast cancer","volume":"7","author":"Mavrommati","year":"2021","journal-title":"npj Breast Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41586-025-09812-3","article-title":"Whole-genome landscapes of 1,364 breast cancers","volume":"649","author":"Kim","year":"2026","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Pal, M., Das, D., and Pandey, M. (2024). Understanding genetic variations associated with familial breast cancer. World J. Surg. Oncol., 22.","DOI":"10.1186\/s12957-024-03553-9"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41588-024-02031-y","article-title":"Refining breast cancer genetic risk and biology through multi-ancestry fine-mapping analyses of 192 risk regions","volume":"57","author":"Jia","year":"2025","journal-title":"Nat. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ekram, S., and Al Eissa, M.M. (2025). A comprehensive framework for the management of hereditary breast cancers: Guiding light in precision medicine. Oncol. Rev., 19.","DOI":"10.3389\/or.2025.1633387"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12672-025-01816-9","article-title":"Next-generation sequencing in cancer diagnosis and treatment: Clinical applications and future directions","volume":"16","author":"Ghoreyshi","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1038\/ncomms6260","article-title":"Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25","volume":"5","author":"Fejerman","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"eabj1624","DOI":"10.1126\/sciadv.abj1624","article-title":"CancerVar: An artificial intelligence\u2013empowered platform for clinical interpretation of somatic mutations in cancer","volume":"8","author":"Li","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9247","DOI":"10.1038\/s41598-019-45723-w","article-title":"The three-hybrid genetic composition of an Ecuadorian population using AIMs-InDels compared with autosomes, mitochondrial DNA and Y chromosome data","volume":"9","author":"Zambrano","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cdd.2017.180","article-title":"Why are there hotspot mutations in the TP53 gene in human cancers?","volume":"25","author":"Baugh","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trecan.2020.01.007","article-title":"TP53 Mutations and Outcomes in breast cancer: Reading beyond the Headlines","volume":"6","author":"Shahbandi","year":"2020","journal-title":"Trends Cancer"},{"key":"ref_20","first-page":"1","article-title":"The Role of TP53 Gene Mutations in the Pathogenesis of breast cancer","volume":"9","author":"Masdiana","year":"2025","journal-title":"Mathews J. Cytol. Histol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/cam4.4652","article-title":"Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients","volume":"11","author":"Liu","year":"2022","journal-title":"Cancer Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/onc.2016.243","article-title":"Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions","volume":"36","author":"Szikriszt","year":"2017","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"a016600","DOI":"10.1101\/cshperspect.a016600","article-title":"Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins","volume":"7","author":"Prakash","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/his.15295","article-title":"E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: The emperor has no clothes","volume":"86","author":"Taha","year":"2025","journal-title":"Histopathology"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"McCart Reed, A.E., Foong, S., Kutasovic, J.R., Nones, K., Waddell, N., Lakhani, S.R., and Simpson, P.T. (2021). The genomic landscape of lobular breast cancer. Cancers, 13.","DOI":"10.3390\/cancers13081950"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/humu.23406","article-title":"Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations","volume":"39","author":"Rebbeck","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10549-023-06892-5","article-title":"BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil","volume":"199","author":"Mazzonetto","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/cam4.5202","article-title":"A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes","volume":"12","author":"Makhnoon","year":"2022","journal-title":"Cancer Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Di Grazia, G., Conti, C., Nucera, S., Motta, G., Martorana, F., Stella, S., Massimino, M., Giuliano, M., and Vigneri, P. (2024). REThinking the role of the RET oncogene in breast cancer. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1427228"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13058-023-01622-7","article-title":"RET signaling in breast cancer therapeutic resistance and metastasis","volume":"25","author":"Pecar","year":"2023","journal-title":"Breast Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13058-015-0610-3","article-title":"ALK alteration is a frequent event in aggressive breast cancers","volume":"17","author":"Siraj","year":"2015","journal-title":"Breast Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"106115","DOI":"10.1016\/j.humpath.2026.106115","article-title":"ALK protein expression and gene copy number alterations in triple-negative breast cancer: Clinical implications","volume":"173","author":"Qiu","year":"2026","journal-title":"Hum. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41588-023-01466-z","article-title":"Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk","volume":"55","author":"Wilcox","year":"2023","journal-title":"Nat. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/cge.12488","article-title":"Use of panel tests in place of single gene tests in the cancer genetics clinic","volume":"88","author":"Yorczyk","year":"2015","journal-title":"Clin. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"107157","DOI":"10.1016\/j.jbc.2024.107157","article-title":"The aryl hydrocarbon receptor-interacting protein in cancer and immunity: Beyond a chaperone protein for the dioxin receptor","volume":"300","author":"Kazzaz","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53","volume":"94","author":"Neto","year":"2011","journal-title":"Neuroendocrinology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Dhotare, P.S., Bochi-Layec, A.C., Fleming, T.P., Gillanders, W.E., Bremner, R.M., Sonawane, K.D., and Sankpal, N.V. (2025). Landscape of cancer associated EpCAM mutations: Molecular modeling, predictive insights and impact on patient survival. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14455-8"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s12282-020-01121-z","article-title":"XPC as breast cancer susceptibility gene: Evidence from genetic profiling, statistical inferences and protein structural analysis","volume":"27","author":"Malik","year":"2020","journal-title":"Breast Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e6716","DOI":"10.1002\/cam4.6716","article-title":"BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancers","volume":"13","author":"Shi","year":"2024","journal-title":"Cancer Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100204","DOI":"10.1016\/j.crphar.2024.100204","article-title":"Targeting c-Met in breast cancer: From mechanisms of chemoresistance to novel therapeutic strategies","volume":"7","author":"Iweala","year":"2024","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s12094-024-03415-6","article-title":"Genomic ancestry and cancer among Latin Americans","volume":"26","author":"Rojas","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/2767-9764.CRC-25-0014","article-title":"Genetic Ancestry, Intrinsic Tumor Subtypes, and Breast Cancer Survival in Latin American Women","volume":"5","author":"Rocha","year":"2025","journal-title":"Cancer Res. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/12\/1964\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:12:13Z","timestamp":1781676733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/12\/1964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18121964"],"URL":"https:\/\/doi.org\/10.3390\/cancers18121964","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}